On Friday, Quest Diagnostics, Inc. (NYSE: DGX) opened higher 0.46% from the last session, before settling in for the closing price of $148.96. Price fluctuations for DGX have ranged from $120.87 to $159.36 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 4.86%. Company’s average yearly earnings per share was noted 2.06% at the time writing. With a float of $110.77 million, this company’s outstanding shares have now reached $111.00 million.
Considering the fact that the conglomerate employs 48000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 32.37%, operating margin of 14.36%, and the pretax margin is 11.94%.
Quest Diagnostics, Inc. (DGX) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Quest Diagnostics, Inc. is 0.49%, while institutional ownership is 89.51%. The most recent insider transaction that took place on Aug 29 ’24, was worth 5,044,516. In this transaction SVP & General Counsel of this company sold 32,551 shares at a rate of $154.97, taking the stock ownership to the 38,478 shares. Before that another transaction happened on Aug 28 ’24, when Company’s SVP, Clinical Solutions sold 1,990 for $153.26, making the entire transaction worth $304,990. This insider now owns 11,459 shares in total.
Quest Diagnostics, Inc. (DGX) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted 2.22 earnings per share (EPS) for the quarter, besting the agreed prediction (set at 2.19) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.85% during the next five years compared to 7.36% growth over the previous five years of trading.
Quest Diagnostics, Inc. (NYSE: DGX) Trading Performance Indicators
Check out the current performance indicators for Quest Diagnostics, Inc. (DGX). In the past quarter, the stock posted a quick ratio of 0.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.78. Likewise, its price to free cash flow for the trailing twelve months is 19.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.41, a number that is poised to hit 2.26 in the next quarter and is forecasted to reach 9.69 in one year’s time.
Technical Analysis of Quest Diagnostics, Inc. (DGX)
Compared to the last year’s volume of 0.91 million, its volume of 0.66 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 53.39%. Additionally, its Average True Range was 2.52.
During the past 100 days, Quest Diagnostics, Inc.’s (DGX) raw stochastic average was set at 59.36%, which indicates a significant increase from 37.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.73% in the past 14 days, which was lower than the 18.59% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $152.52, while its 200-day Moving Average is $139.59. Nevertheless, the first resistance level for the watch stands at $150.84 in the near term. At $152.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $153.48. If the price goes on to break the first support level at $148.21, it is likely to go to the next support level at $146.76. Now, if the price goes above the second support level, the third support stands at $145.57.
Quest Diagnostics, Inc. (NYSE: DGX) Key Stats
There are currently 111,092K shares outstanding in the company with a market cap of 16.66 billion. Presently, the company’s annual sales total 9,252 M according to its annual income of 854,000 K. Last quarter, the company’s sales amounted to 2,397 M and its income totaled 229,000 K.
